Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Rational Design of Toxoid Vaccine Candidates for Staphylococcus aureus Leukocidin AB (LukAB).

Kailasan S, Kort T, Mukherjee I, Liao GC, Kanipakala T, Williston N, Ganjbaksh N, Venkatasubramaniam A, Holtsberg FW, Karauzum H, Adhikari RP, Aman MJ.

Toxins (Basel). 2019 Jun 14;11(6). pii: E339. doi: 10.3390/toxins11060339.

2.

Potent Neutralization of Staphylococcal Enterotoxin B In Vivo by Antibodies that Block Binding to the T-Cell Receptor.

Chen G, Karauzum H, Long H, Carranza D, Holtsberg FW, Howell KA, Abaandou L, Zhang B, Jarvik N, Ye W, Liao GC, Gross ML, Leung DW, Amarasinghe GK, Aman MJ, Sidhu SS.

J Mol Biol. 2019 Oct 4;431(21):4354-4367. doi: 10.1016/j.jmb.2019.03.017. Epub 2019 Mar 27.

PMID:
30928493
3.

TBA225, a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigens.

Venkatasubramaniam A, Adhikari RP, Kort T, Liao GC, Conley S, Abaandou L, Kailasan S, Onodera Y, Krishnan S, Djagbare DM, Holtsberg FW, Karauzum H, Aman MJ.

Sci Rep. 2019 Mar 1;9(1):3279. doi: 10.1038/s41598-019-39890-z.

4.

Effective Treatment of Staphylococcal Enterotoxin B Aerosol Intoxication in Rhesus Macaques by Using Two Parenterally Administered High-Affinity Monoclonal Antibodies.

Verreault D, Ennis J, Whaley K, Killeen SZ, Karauzum H, Aman MJ, Holtsberg R, Doyle-Meyers L, Didier PJ, Zeitlin L, Roy CJ.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02049-18. doi: 10.1128/AAC.02049-18. Print 2019 May.

5.

Vaccine display on artificial bacterial spores enhances protective efficacy against Staphylococcus aureus infection.

Karauzum H, Updegrove TB, Kong M, Wu IL, Datta SK, Ramamurthi KS.

FEMS Microbiol Lett. 2018 Sep 1;365(18). doi: 10.1093/femsle/fny190.

6.

STAT-3-independent production of IL-17 by mouse innate-like αβ T cells controls ocular infection.

St Leger AJ, Hansen AM, Karauzum H, Horai R, Yu CR, Laurence A, Mayer-Barber KD, Silver P, Villasmil R, Egwuagu C, Datta SK, Caspi RR.

J Exp Med. 2018 Apr 2;215(4):1079-1090. doi: 10.1084/jem.20170369. Epub 2018 Feb 28.

7.

Lethal CD4 T Cell Responses Induced by Vaccination Against Staphylococcus aureus Bacteremia.

Karauzum H, Haudenschild CC, Moore IN, Mahmoudieh M, Barber DL, Datta SK.

J Infect Dis. 2017 Apr 15;215(8):1231-1239. doi: 10.1093/infdis/jix096.

8.

Adaptive Immunity Against Staphylococcus aureus.

Karauzum H, Datta SK.

Curr Top Microbiol Immunol. 2017;409:419-439. doi: 10.1007/82_2016_1.

9.

CARD9-Dependent Neutrophil Recruitment Protects against Fungal Invasion of the Central Nervous System.

Drummond RA, Collar AL, Swamydas M, Rodriguez CA, Lim JK, Mendez LM, Fink DL, Hsu AP, Zhai B, Karauzum H, Mikelis CM, Rose SR, Ferre EM, Yockey L, Lemberg K, Kuehn HS, Rosenzweig SD, Lin X, Chittiboina P, Datta SK, Belhorn TH, Weimer ET, Hernandez ML, Hohl TM, Kuhns DB, Lionakis MS.

PLoS Pathog. 2015 Dec 17;11(12):e1005293. doi: 10.1371/journal.ppat.1005293. eCollection 2015 Dec.

10.

Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.

Karauzum H, Adhikari RP, Sarwar J, Devi VS, Abaandou L, Haudenschild C, Mahmoudieh M, Boroun AR, Vu H, Nguyen T, Warfield KL, Shulenin S, Aman MJ.

PLoS One. 2013 Jun 7;8(6):e65384. doi: 10.1371/journal.pone.0065384. Print 2013.

11.

Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections.

Adhikari RP, Ajao AO, Aman MJ, Karauzum H, Sarwar J, Lydecker AD, Johnson JK, Nguyen C, Chen WH, Roghmann MC.

J Infect Dis. 2012 Sep 15;206(6):915-23. doi: 10.1093/infdis/jis462. Epub 2012 Jul 17.

PMID:
22807524
12.

Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia.

Adhikari RP, Karauzum H, Sarwar J, Abaandou L, Mahmoudieh M, Boroun AR, Vu H, Nguyen T, Devi VS, Shulenin S, Warfield KL, Aman MJ.

PLoS One. 2012;7(6):e38567. doi: 10.1371/journal.pone.0038567. Epub 2012 Jun 6.

13.

Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome.

Karauzum H, Chen G, Abaandou L, Mahmoudieh M, Boroun AR, Shulenin S, Devi VS, Stavale E, Warfield KL, Zeitlin L, Roy CJ, Sidhu SS, Aman MJ.

J Biol Chem. 2012 Jul 20;287(30):25203-15. doi: 10.1074/jbc.M112.364075. Epub 2012 May 29.

14.
15.

Superantigen-presentation by rat major histocompatibility complex class II molecules RT1.Bl and RT1.Dl.

Dlaske H, Karaüzüm H, Monzon-Casanova E, Rudolf R, Starick L, Müller I, Wildner G, Diedrichs-Möhring M, Koch N, Miyoshi-Akiyama T, Uchiyama T, Wonigeit K, Fleischer B, Overbeck S, Rink L, Herrmann T.

Immunology. 2009 Sep;128(1 Suppl):e572-81. doi: 10.1111/j.1365-2567.2008.03033.x. Epub 2008 Dec 24.

16.

Comparison of adhesion and virulence of two predominant hospital-acquired methicillin-resistant Staphylococcus aureus clones and clonal methicillin-susceptible S. aureus isolates.

Karauzum H, Ferry T, de Bentzmann S, Lina G, Bes M, Vandenesch F, Schmaler M, Berger-Bächi B, Etienne J, Landmann R.

Infect Immun. 2008 Nov;76(11):5133-8. doi: 10.1128/IAI.01697-07. Epub 2008 Sep 8.

17.

In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.

McCallum N, Karauzum H, Getzmann R, Bischoff M, Majcherczyk P, Berger-Bächi B, Landmann R.

Antimicrob Agents Chemother. 2006 Jul;50(7):2352-60.

Supplemental Content

Loading ...
Support Center